These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36245987)
1. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma. Xu F; Xiong N; Yuan Y; Liu J J Oncol; 2022; 2022():5244820. PubMed ID: 36245987 [TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Cao K; Ling X; Jiang X; Ma J; Zhu J Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897 [TBL] [Abstract][Full Text] [Related]
3. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database. Wu ZH; Zhang YJ; Sun HY Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847 [TBL] [Abstract][Full Text] [Related]
4. FOXA1/UBE2T Inhibits CD8 Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180 [TBL] [Abstract][Full Text] [Related]
5. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786 [TBL] [Abstract][Full Text] [Related]
6. Independent prognostic implications of Ma C; Luo H; Cao J; Gao C; Fa X; Wang G J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291 [No Abstract] [Full Text] [Related]
7. Overexpression and diagnostic significance of INTS7 in lung adenocarcinoma and its effects on tumor microenvironment. Li X; Yao Y; Qian J; Jin G; Zeng G; Zhao H Int Immunopharmacol; 2021 Dec; 101(Pt B):108346. PubMed ID: 34781123 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5). Li Y; Yang X; Lu D Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375 [TBL] [Abstract][Full Text] [Related]
9. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications. Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
11. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures. Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114 [TBL] [Abstract][Full Text] [Related]
12. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma. Zhu J; Ao H; Liu M; Cao K; Ma J J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934 [TBL] [Abstract][Full Text] [Related]
13. Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC). Zhang L; Chen J; Cheng T; Yang H; Li H; Pan C J Cancer; 2020; 11(17):4965-4979. PubMed ID: 32742444 [TBL] [Abstract][Full Text] [Related]
14. A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with Fu J; Li Y; Li C; Tong Y; Li M; Cang S Transl Cancer Res; 2021 Sep; 10(9):3963-3978. PubMed ID: 35116695 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
16. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related]
18. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH PeerJ; 2020; 8():e9530. PubMed ID: 32775050 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma. Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345 [No Abstract] [Full Text] [Related]
20. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma. Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]